ANN ARBOR FIRM WITH UW DRUG TECH GOES PUBLIC
QuatRx Pharmaceuticals Co., a pharmaceutical firm in Ann Arbor, Michigan, that
licensed some of University of Wisconsin-Madison professor Hector DeLuca's technology
in 2002, has filed for an IPO. One of the company's five products is a treatment
for psoriasis, a skin disease, based on DeLuca's work at UW-Madison and Deltanoid
Pharmaceuticals. It is licensed through the Wisconsin Alumni Association.
Wisconsin Technology Network